Post-earnings recap
Reported
Thu, May 9, 2024
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Charles River Laboratories reported better-than-expected earnings per share, beating estimates by 10.68%. However, the stock reacted negatively, declining by 2.21%. The lack of revenue data and management commentary may have contributed to investor uncertainty.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.27 | N/A | +10.68% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based solely on numerical results.